Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1

AUTOR(ES)

Cunha, Karin Soares Gonçalves, Barboza, Eliane Porto, Fonseca, Eliene Carvalho da

FONTE

Clinics

DATA DE PUBLICAÇÃO

2008

RESUMO

OBJECTIVE: The aim of this study was to investigate the presence of growth hormone receptor in plexiform neurofibromas of neurofibromatosis type 1 patients. INTRODUCTION: The development of multiple neurofibromas is one of the major features of neurofibromatosis type 1. Since neurofibromas commonly grow during periods of hormonal change, especially during puberty and pregnancy, it has been suggested that hormones may influence neurofibromatosis type 1 neurofibromas. A recent study showed that the majority of localized neurofibromas from neurofibromatosis type 1 patients have growth hormone receptor. METHODS: Growth hormone receptor expression was investigated in 5 plexiform neurofibromas using immunohistochemistry. RESULTS: Four of the 5 plexiform neurofibromas were immunopositive for growth hormone receptor. CONCLUSION: This study suggests that growth hormone may influence the development of plexiform neurofibromas in patients with neurofibromatosis type 1.

Documentos Relacionados

• Resection of small plexiform neurofibromas in neurofibromatosis type 1 children
• High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1
• Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1
• A rare case of cervical hypoglossal nerve neurofibromas in a patient with type 1 neurofibromatosis
• Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas